Effects of noradrenaline and flow on lactate uptake in the perfused rat hindlimb.
Skeletal muscle can release or take up lactate depending on the lactate concentration gradient across the cell membrane. In the perfused rat hindlimb without arterial lactate, both noradrenaline (NA) infusion and increased flow promote lactate release and oxygen consumption (VO2). However, it is unclear whether NA or increased flow rate have similar effects on lactate uptake. The present study compares these effects in the rat hindlimb perfused at a basal flow rate of 0.33 mL min-1 g-1 and 25 degrees C in the presence of added arterial lactate. When 10 mmol L-1 L-(+)-lactate was added to the arterial perfusate, lactate was taken up (16 +/- 1.0 mumol g-1 h-1, n = 13) by the hindlimb with a 35% higher VO2 than that without added lactate. Doubling perfusion flow rate enhanced lactate uptake and VO2 by 120% and 40%, respectively. Glucose uptake was also increased (by 253%) with increased flow. Infusion of NA increased perfusion pressure, VO2 and glucose uptake similarly to those induced by increased flow rate. However, lactate uptake was inhibited by NA. This inhibition was not altered by the beta-adrenergic antagonist propranolol. Vasopressin also showed similar effects to NA to decrease lactate uptake associated with increased VO2 and vasoconstriction. These data indicate that in the presence of a high arterial lactate concentration, NA has opposite effects from increased flow rate on skeletal muscle lactate uptake although both have similar effects on lactate release in the absence of arterial lactate. Inhibition of lactate uptake may relate to the vasoconstrictive action of NA.
Ye
J M
JM
Division of Biochemistry, University of Tasmania, Hobart, Australia.
Steen
J T
JT
Matthias
A
A
Clark
M G
MG
Colquhoun
E Q
EQ
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D006614:Hindlimb; D019344:Lactic Acid / Q000493:pharmacokinetics*; D008297:Male; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow / Q000502:physiology; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D014662:Vasoconstrictor Agents; D019344:Lactic Acid; D009638:Norepinephrine